David Veesler

From Wikipedia, the free encyclopedia

David Veesler is a French biochemist and an assistant professor in the Department of Biochemistry at the University of Washington,[1] where his group focuses on the study the structural biology of infectious diseases.[2] His team recently helped determine the structure of the SARS-CoV-2 spike glycoprotein [3] using Cryo-EM techniques, and it is currently trying to identify neutralizing antibodies for SARS-CoV-2 that could be used as a preventative treatment against COVID-19 or as a post-exposure therapy[4] using X-ray crystallography.[5] Veesler is Howard Hughes Medical Investigators.[6]

Education[]

David Veesler earned his Ph.D. from Aix-Marseille University in France in 2010. He was a visiting researcher at the University of Zurich in Switzerland during his PhD, and joined the Scripps Research Institute in La Jolla, California as postdoctoral fellow from 2011 to 2014 before joining the University of Washington.[7]

Awards and honors[]

  • 2013 Microscopy Society of America Presidential Scholar Award
  • 2012 The Scripps Research Institute Fall Research Symposium Award
  • 2011 Marie-Curie International Outgoing Postdoctoral Fellowship
  • 2011 French Crystallographic Association PhD award
  • 2009 Wyatt Technology award
  • 2006 French Ministry of Higher Education and Research PhD fellowship

References[]

  1. ^ David Veesler faculty profile, University of Washington
  2. ^ Veesler Lab website
  3. ^ Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell (2020)
  4. ^ Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature (2020)
  5. ^ X-ray Experiments Zero in on COVID-19 Antibodies – Berkeley Lab News Center
  6. ^ HHMI Invests $300 Million in 33 New Investigators – HHMI
  7. ^ David Veesler – CV, University of Washington
Retrieved from ""